Uhthoff's Phenomenon—A Scare or Real Threat to Multiple Sclerosis Patients? A Narrative Review

1. Introduction

Multiple sclerosis (MS) is a chronic, immune-mediated neurodegenerative disorder of the central nervous system (CNS) characterized by a highly heterogeneous clinical presentation and an unpredictable disease course that frequently leads to progressive disability. While classic clinical progression is traditionally defined by acute inflammatory relapses followed by periods of remission, transient symptom fluctuations independent of novel focal neuroinflammation present an equally critical challenge in routine clinical practice. Among these, heat sensitivity stands out as one of the most prevalent and disruptive features of the disease, frequently manifesting as Uhthoff’s phenomenon (UP)—a temporary, temperature-dependent worsening of pre-existing neurological deficits.

Recent epidemiological evidence synthesized by Khan and Hashim (2025) highlights a significant escalation in the global burden of MS over the past three decades. The distribution of MS correlates strongly with geographical latitude, age of onset, and socio-demographic factors, reflecting a complex, multifactorial interplay between polygenic susceptibility and environmental triggers, such as Epstein-Barr virus (EBV) exposure and vitamin D deficiency. Analysis of the Global Burden of Disease (GBD) Study 2021 indicates that approximately 1.89 million individuals are living with MS worldwide, with over 62,000 incident cases recorded in 2021 alone. This corresponds to a global prevalence rate of 23.9 cases per 100,000 population. Notably, the epidemiological burden exhibits substantial gender and age-specific asymmetry; women are approximately twice as likely as men to be diagnosed with MS, with the highest incidence rates concentrated within the young adult population aged 15 to 40 years.

Explicitly highlighting this gender asymmetry, the global prevalence of MS among women is estimated at 32.3 per 100,000 individuals (95% uncertainty interval [UI]: 29.1–36.1), nearly doubling the prevalence of 15.6 per 100,000 (95% UI: 13.8–17.6) observed in men. The peak incidence of the disease occurs between 30 and 34 years of age. Consequently, the predilection of MS for young women during their peak reproductive and socio-professional years inflicts profound socio-economic burdens, severely impacting workforce participation and family planning [1].

The historical foundation of heat sensitivity in MS traces back to Wilhelm Uhthoff, a prominent German ophthalmologist who significantly shaped early neuro-ophthalmology. In 1890, Uhthoff documented a distinct clinical phenomenon involving transient visual disturbances in MS patients following physical exertion [2,3,4]. In his initial cohort, he observed that four out of 100 individuals experienced a “marked deterioration in visual acuity during physical effort and exhaustion,” driven by elevated core body temperature. By 1904, Uhthoff further postulated that this reversible amblyopia was fundamentally linked to structural demyelination, particularly within the optic nerve pathways [6]. This transient exacerbation was subsequently formalized in 1961 by G. Ricklefs, who coined the term “Uhthoff’s phenomenon” (UP) [5]. Over the ensuing decades, UP has expanded from its initial neuro-ophthalmological definition to encapsulate a broader spectrum of temperature-dependent neurological fluctuations, prompting extensive research into its precise pathophysiological mechanisms.

Historically, Davis et al. (2010) estimated that UP affects between 60% and 80% of individuals diagnosed with MS at least once during their lifetime [7]. However, as discussed comprehensively in Section 4, these widely cited prevalence ranges must be interpreted with caution due to substantial methodological heterogeneity, a heavy reliance on self-reported patient questionnaires, and the absence of standardized clinical definitions across different epidemiological cohorts. Despite these statistical variations, there is a strong consensus that even minor elevations in core body temperature serve as the primary catalyst for UP. While historically confined to visual acuity deficits, contemporary clinical observations indicate that thermal stress frequently exacerbates symptoms across multiple neurological domains, including postural stability, motor strength, cognitive processing, and somatosensory functions [8]. During the latter half of the 20th century, this high thermal sensitivity was leveraged diagnostically via the “hot bath test.” This provocative tool was subsequently discontinued and fell out of clinical favor due to its low diagnostic specificity, the advent of advanced neuroimaging techniques, and the ethical implications of inducing severe, albeit temporary, neurological distress in vulnerable patients [9].

2. Methodology

2.1. Objectives

This narrative review provides a comprehensive synthesis of the historical and contemporary literature regarding Uhthoff’s phenomenon (UP) in multiple sclerosis (MS). The specific objectives are to:

• Formulate a precise definition of UP and contextualize its relationship with systemic thermal sensitivity in MS;
• Critically appraise its epidemiology, exploring the methodological limitations and heterogeneity of current prevalence estimates;
• Delineate the multifaceted pathophysiological mechanisms of UP, integrating traditional neurophysiological models with modern concepts of mitochondrial dysfunction, neuroenergetic failure, inflammatory mediators, and autonomic dysregulation;
• Outline pragmatic clinical criteria to differentiate temperature-dependent pseudo-relapses from acute inflammatory relapses;
• Review current therapeutic and preventive management strategies, establishing a clear distinction between robust evidence-based interventions and expert-informed practical guidance regarding cooling modalities, rehabilitative planning, and pharmacological approaches.

2.2. Literature Search Strategy

A comprehensive literature search was conducted across major electronic databases, including PubMed/MEDLINE, Scopus, Web of Science, CINAHL, and PsycINFO. The search architecture incorporated combinations of Medical Subject Headings (MeSH) and free-text keywords related to the core focus of this review, specifically: “Uhthoff’s phenomenon,” “multiple sclerosis,” “exercise,” “heat sensitivity,” “rehabilitation,” “cooling,” “pseudo-relapse,” “demyelination,” and “fatigue.” The comprehensive bibliographical search spanned literature published from historical inception in 1890 through April 2026.

Eligibility for inclusion comprised peer-reviewed primary studies, reviews, theses, and clinical case reports published in English or German, evaluating adult populations (≥18 years) with a confirmed diagnosis of MS. Eligible literature was required to investigate the clinical manifestations of Uhthoff’s phenomenon, heat exposure dynamics, neurophysiological nerve conduction alterations, or the physiological impacts of exercise and physical rehabilitation. Conversely, exclusion criteria were applied to non-peer-reviewed literature, conference abstracts, gray literature, and studies focusing exclusively on pediatric MS cohorts or caregiver perspectives.

Literature screening and subsequent data extraction were conducted independently by two reviewers through an initial title and abstract analysis, followed by a rigorous full-text eligibility assessment. Discrepancies regarding study inclusion were resolved via investigator consensus. Extracted data points of interest encompassed study design, cohort characteristics, clinical phenotypes, and specific outcome measurement tools. Following this selection protocol, a total of 69 articles, foundational theses, and book chapters were identified as meeting the baseline criteria. A significant proportion of the retrieved earlier literature was classified as holding predominantly historical significance, serving to contextualize the evolution of contemporary clinical perspectives on thermal dysregulation in MS. Given the narrative nature of this review, formal meta-analytical procedures and systematic risk-of-bias assessments were not performed; instead, primary emphasis was placed on a critical qualitative analysis of the retrieved literature and its limitations.

3. Definition of Uhthoff`s Phenomenon

Uhthoff’s phenomenon (UP) is classically defined as a transient, fully reversible exacerbation of pre-existing neurological deficits secondary to minor elevations in core body temperature, often by as little as 0.2 °C to 0.5 °C. These recrudescent symptoms characteristically resolve spontaneously once normothermia is restored. While clinical consensus and narrative reports emphasize the paroxysmal nature of these episodes—typically lasting from several minutes to a few hours—formal quantitative evidence defining their precise temporal boundaries remains limited; nevertheless, by current operational definitions, an episode must not exceed a 24-hour threshold. This thermal sensitivity can be precipitated by a broad spectrum of pyrogenic and non-pyrogenic factors. These include environmental hyperthermia (e.g., hot weather, hot water immersion, and sauna use), metabolic heat production via physical exertion, psychological stress, and underlying infectious processes. Additionally, small-scale observational data and clinical experience suggest that cyclical hormonal fluctuations, such as those occurring during menstruation or ovulation, may lower the thermal threshold for symptom manifestation.

In contemporary neuroimmunological practice, UP is categorized as a pseudo-relapse, representing a functional clinical fluctuation driven by external or systemic stressors in the absolute absence of novel focal neuroinflammatory activity or acute demyelination within the central nervous system (CNS) [8]. Conversely, a true multiple sclerosis (MS) relapse is pathogenetically underpinned by acute, active inflammatory lesion formation, operationally defined as the onset of novel neurological symptoms or the objective worsening of stable deficits persisting for a minimum of 24 to 48 hours, occurring in a state of clinical stability and independent of confounding systemic triggers. Differentiating these entities is of paramount clinical importance; pyrexia, for instance, serves a dual role as both an immediate physical trigger for UP and a critical diagnostic indicator of an underlying pathological process—such as a urinary tract infection—that requires prompt targeted antimicrobial intervention rather than inappropriate corticosteroid immunotherapy.

4. The Epidemiology and Clinical Significance of Heat Sensitivity

Systemic heat sensitivity represents one of the most prevalent yet clinically underestimated facets of multiple sclerosis (MS). Welfare reports and aggregated literature frequently estimate that Uhthoff’s phenomenon (UP), or broader thermal sensitivity, affects approximately 60% to 80% of individuals with MS [7]. However, these figures exhibit substantial variability. This statistical fluctuation is primarily driven by striking methodological heterogeneity, including divergent operational definitions of heat sensitivity, a heavy reliance on subjective patient recall versus objective neurophysiological testing, and regional variations in climatic exposure among the populations studied [51]. Illustrating this variability, specific longitudinal observations report a lower baseline of 52% of patients experiencing manifest UP over follow-up periods spinning one to twenty years.

Furthermore, the clinical expression of thermal stress is highly widespread; among MS patients exhibiting UP, up to 88% report concomitant non-visual neurological exacerbations, compared to only 30% of heat-sensitive individuals without classical visual amblyopia [11]. Regarding temporal dynamics, while a minority of patients (approximately 16%) demonstrate complete clinical resolution of persistent thermal vulnerability within an eight-week window, prolonged symptom susceptibility beyond two months correlates heavily with compromised remyelination and chronic axonal vulnerability. For most individuals, the clinical presentation of UP is highly stereotyped and predictable, manifesting as “patterned” symptom exacerbations unique to the patient. While this clinical predictability can empower patients to recognize pseudo-relapses independently, it frequently engenders hyper-vigilance, leading to maladaptive behaviors such as the systematic avoidance of physical, rehabilitative, and social activities [11].

Early hypotheses regarding the etiology of MS-related thermal sensitivity, such as those postulated by Guthrie and Nelson, suggested a highly multifactorial framework encompassing transient serum calcium fluctuations, primitive models of ion channel blockade, altered peripheral circulation, and heat shock protein expression [12]. However, contemporary neurobiological insights have heavily refined this paradigm. Modern concepts indicate that while these systemic circulatory and humoral shifts play a minor contributory role, the primary drivers of thermal vulnerability are structurally anchored within the demyelinated axon itself. Specifically, as detailed in Section 5, the pathomechanism is now understood to involve an intricate interplay between temperature-dependent conduction blocks, acute neuroenergetic failure, mitochondrial dysfunction, and focal autonomic dysregulation, which collectively lower the physiological threshold required to disrupt compromised neurological pathways [56].

5. Pathophysiological Mechanisms of Uhthoff’s Phenomenon

Efforts to elucidate the pathomechanisms underpinning Uhthoff’s phenomenon (UP) span more than a century [13,14,15,16]. While the traditional biophysical paradigm identifies temperature-dependent conduction block along demyelinated axons as the primary driver, contemporary neurobiological frameworks reveal a far more complex, multi-faceted cascade [56]. In structurally compromised, demyelinated neural pathways, the saltatory conduction of action potentials is lost, necessitating the diffuse redistribution and compensatory upregulation of voltage-gated sodium channels along the denuded axolemma to maintain basic impulse propagation. However, this structural remodeling imposes an extraordinary metabolic penalty, markedly increasing the energy requirement of the Na⁺/K⁺-ATPase pump to maintain resting membrane potentials.

This precarious bioenergetic state is highly vulnerable to thermal stress. Elevated core body temperature exacerbates this underlying neuroenergetic failure via widespread mitochondrial dysfunction [49]. Thermal stress directly impairs mitochondrial respiratory chain efficiency, crippling adenosine triphosphate (ATP) synthesis precisely when the metabolic demands of the hyperactive ion pumps peak [49]. This severe energy mismatch renders the axon incapable of sustaining continuous depolarization.

Furthermore, this bioenergetic crisis is compounded by microenvironmental factors and inflammatory mediators [50]. Minor elevations in temperature accelerate the kinetics and promote the local release of pro-inflammatory cytokines (such as IL-1, IL-6, and TNF-α) and reactive nitrogen species, such as nitric oxide (NO), which directly inhibit mitochondrial complexes and worsen transient axonal conduction failure [50]. Systemic heat sensitivity in MS is further exacerbated by autonomic dysregulation. Demyelinating lesions within central autonomic pathways frequently impair sudomotor responses and blunt peripheral thermoregulatory effector mechanisms, creating a maladaptive cycle where the body cannot efficiently dissipate heat, thereby lowering the threshold for UP manifestation in the absence of acute, active neuroinflammation [56].

Contextualizing these systemic vulnerabilities, Davis et al. categorized thermoregulatory disturbances in MS into five distinct clinical and physiological domains: (1) subjective heat sensitivity, (2) altered central regulation of core body temperature, (3) compromised responsiveness of thermoregulatory effectors, (4) heat-induced central fatigue, and (5) targeted interventions aimed at preserving neurological function during thermal stress [9].

To quantify these electrophysiological alterations, Humm et al. conducted a foundational objective assessment in a cohort of 20 MS patients, utilizing motor-evoked potentials (MEPs) to evaluate central axonal conduction kinetics under thermal duress [17]. Their findings demonstrated that even minor temperature elevations induced a significant prolongation of the central motor conduction time (CMCT, p = 0.037), directly capturing the real-time slowing of motor fiber conduction velocity. Crucially, this subclinical electrophysiological degradation translated directly into manifest functional impairment, as evidenced by a highly significant reduction in objective walking speed (p = 0.0002) [17].

Beyond generalized neurological deficits, Uhthoff’s phenomenon is distinctly observed in patients presenting with internuclear ophthalmoplegia (INO)—a localized brainstem syndrome resulting from structural damage to the medial longitudinal fasciculus (MLF). The MLF serves as a critical heavily myelinated pathway interconnecting the contralateral abducens nerve nucleus with the ipsilateral oculomotor nerve motor nucleus to coordinate conjugate horizontal gaze. Clinically, INO manifests as impaired adduction of the ipsilateral eye during lateral conjugate movements, accompanied by a dissociated horizontal nystagmus of the contralateral abducting eye. While cerebrovascular accidents represent a leading cause of INO in older cohorts, its presence in young adults is predominantly secondary to MS, with bilateral involvement widely considered pathognomonic for central demyelination. Less frequent etiologies include brainstem neoplasms, syringobulbia, acute drug toxicities, and Wernicke’s encephalopathy. Given its highly stereotyped anatomy and easily quantifiable deficits, Leigh et al. postulated that INO represents an ideal, reproducible in vivo model for examining the real-time neurophysiological impacts of thermal stress on axonal transmission, as well as evaluating the efficacy of novel neuroprotective interventions [18].

Utilizing this specific clinical model, Davis et al. demonstrated in a cohort of eight MS patients that an elevation in core body temperature by as little as 0.8 °C induced a measurable reduction in the velocity and tracking efficiency of adductive saccades [19]. This transient functional decay is fundamentally driven by a temperature-dependent deceleration in axonal conduction kinetics. Crucially, this impairment remains fully reversible; subsequent core body cooling actively mitigates these saccadic deficits, restoring baseline oculomotor performance [19].

Providing deeper molecular insights into this thermal vulnerability, Howells et al. (2013) elucidated that minor shifts in temperature (ranging from 0.2 °C to 0.5 °C) significantly accelerate the inactivation kinetics of voltage-gated sodium channels along demyelinated segments, effectively short-circuiting the sustained depolarization phase necessary to propagate an action potential [20]. In healthy, heavily myelinated pathways, conduction is protected by a substantial “safety factor”—defined biophysically as the ratio of the electrical current generated by an action potential to the minimum threshold current required to depolarize the adjacent axonal segment [20,56]. Structural demyelination severely degrades this safety factor, leaving the axon with virtually no functional reserve [56]. Consequently, even the minor ion channel gating alterations induced by micro-elevations in temperature are sufficient to tip the compromised axon into a complete, albeit temporary, conduction block.

Moreover, recent insights from Frohman et al. in Nature Reviews Neurology underscore that while the clinical manifestation resolves quickly, each episode of neuroenergetic collapse and mitochondrial failure induces localized oxidative stress [56]. Over prolonged periods, repeated exposure of vulnerable axons to these transient bioenergetic crises can accelerate chronic axonal degeneration, directly contributing to permanent disability progression in progressive MS phenotypes [49,56].

6. Clinical Presentation and Diagnostics

6.1. Thermal and Non-Thermal Triggers of Uhthoff’s Phenomenon

Uhthoff’s phenomenon (UP) is characterized by its high susceptibility to various exogenous and endogenous factors that alter core body temperature or autonomic stability. Based on current clinical observations, the primary precipitating factors contributing to these transient neurological exacerbations are classified into the following domains [8,51]:

• Elevated Environmental Temperature and Ambient Humidity: Prolonged exposure to high seasonal ambient heat (e.g., during summer months), poorly ventilated or overheated indoor environments, and the usage of excessively insulating or occlusive clothing [55];
• Metabolic Heat Production via Physical Exertion: Sustained physical effort, particularly prolonged aerobic activities or high-intensity rehabilitation, especially when proactive cooling strategies or environmental microclimate controls are insufficient to dissipate metabolic heat [53,54];
• Infectious and Post-Vaccination Pyrexia: Systemic fever secondary to underlying acute infectious processes—most notably upper respiratory tract infections and urinary tract infections (UTIs)—as well as transient febrile reactions following vaccinations or other systemic inflammatory conditions;
• Exogenous Thermal Immersion and Radiant Heat Exposure: Direct exposure to hot baths, showers, saunas, jacuzzis, heated therapeutic pools, or prolonged, direct sun exposure [51];
• Endocrine and Neuroendocrine Fluctuations: Transient core temperature spikes and vasomotor symptoms, such as hot flashes occurring during the perimenopausal period, as well as cyclical hormonal shifts during ovulation or menstruation.

6.2. Clinical Manifestations and Phenotypes of Uhthoff’s Phenomenon

The clinical presentation of Uhthoff’s phenomenon (UP) is highly heterogeneous, directly reflecting the anatomical topography of pre-existing, clinically silent, or chronically demyelinated lesions within the central nervous system (CNS). Under thermal stress, these subclinical deficits manifest across multiple functional domains [8,56]:

• Neuro-Ophthalmological Symptoms: Characterized by transient visual acuity degradation (classic Uhthoff’s amblyopia), impaired contrast sensitivity, glare intolerance, chromatopsia (color desaturation), and the temporary exacerbation of pre-existing diplopia or oscillopsia secondary to nystagmus.
• Motor and Coordinate Symptoms: Manifesting as acute, reversible lower limb paresis, increased spasticity, foot drop, postural instability, ataxia, and a quantifiable deceleration in gait velocity.
• Somatosensory Symptoms: Precipitating or intensifying paroxysmal paresthesia, hypoesthesia, dysesthesia, or burning neuropathic pain.
• Cognitive and Autonomic Symptoms: Encompassing transient slowing of information processing speed, attention deficits, and acute worsening of autonomic dysregulation, such as urinary urgency, incomplete bladder emptying, and orthostatic intolerance. These fluctuations are notably exacerbated by concomitant dehydration or physical exertion.

A prominent and pervasive manifestation of thermal stress is the acute exacerbation of fatigue. While general MS-related fatigue is highly prevalent—affecting an estimated 75% to 90% of patients through complex central and peripheral mechanisms—its interaction with temperature is particularly profound [22]. Literature indicates that heat exposure worsens fatigue in approximately 69% to 92% of individuals; however, these wide ranges must be critically interpreted, as they rely heavily on self-reported questionnaires and exhibit substantial heterogeneity based on regional climate variations [8]. This thermal-fatigue interplay is increasingly critical in the context of global climate shift and escalating heatwave frequencies [23]. Notably, some evidence suggests that patients with relapsing-remitting MS (RRMS) may exhibit a persistently elevated resting core body temperature, which directly correlates with baseline fatigue severity even in the absence of external thermal challenges [4].

The transient recurrence of these multi-domain symptoms carries severe secondary psychological and behavioral consequences. The predictable yet distressing nature of UP frequently induces profound kinesiophobia and a heightened fear of falling [21]. Epidemiological data, including recent insights by Patel et al. (2025), indicate that up to 37% of individuals with MS experience a pervasive fear of falling, while actual fall prevalence reaches 50% [26]. When amplified by thermal stress, this anxiety—frequently compounded by comorbid depression—engenders a maladaptive cycle of hyper-vigilance [24,25]. Consequently, patients often engage in the systematic avoidance of physical rehabilitation and essential social activities, inadvertently accelerating physical deconditioning and severely diminishing their overall quality of life.

6.3. Clinical Course and Prognosis

The clinical course of Uhthoff’s phenomenon (UP) is typically benign, characterized by a highly favorable long-term functional prognosis. Manifestations generally initiate within minutes of exposure to thermal stress or physical exertion and resolve spontaneously upon core body cooling, cessation of activity, or cessation of the precipitating factor. Conventionally, symptoms are expected to subside within a 24-hour window; however, it is critical to note that this temporal boundary serves as an operational diagnostic threshold rather than a strictly validated biological rule. Chronic or permanent neurological sequelae directly attributable to UP are exceedingly rare.

Patients frequently experience these fluctuations as a highly transient, cyclical shift in baseline function [8]. For instance, a patient’s gait profile may remain stable during early morning normothermia but degrade significantly following midday heat exposure or hot water immersion. Because the severity and duration of UP symptoms vary daily—modulated by external meteorological conditions, systemic hydration levels, and individual metabolic activity—these transient episodes are frequently misinterpreted by both patients and clinicians as disease progression or an active inflammatory relapse. This diagnostic ambiguity carries substantial behavioral risks; the anticipation of thermal distress often prompts patients to engage in preemptive avoidance of heat-inducing activities, inadvertently fostering sedentary behavior, reducing physical rehabilitation compliance, and restricting social participation.

6.4. Diagnostic Assessment and Differential Evaluation

The clinical diagnosis of Uhthoff’s phenomenon (UP) fundamentally relies on a meticulous, structured patient anamnesis. Evaluating a suspected presentation requires confirming a stereotypical, fully reversible recrudescence of pre-existing neurological deficits that is strictly linked temporally to an identifiable thermal stressor. Key anamnesty criteria that clinicians must systematically evaluate include:

• Symptom Topography: Identifying the specific neurological domains affected (e.g., visual acuity, gait parameters, sphincter control, or cognitive processing speed);
• Trigger Identification: Delineating the precise exogenous or endogenous catalysts (e.g., hot water immersion, ambient meteorological hyperthermia, pyrexia, or metabolic heat from exercise);
• Temporal Dynamics: Quantifying the exact latency between thermal exposure and symptom onset, as well as the duration required for complete clinical resolution;
• Thermoregulatory Responsiveness: Confirming whether targeted cooling strategies (e.g., ingestion of cold fluids, fan-induced convection, or rest in a climate-controlled environment) consistently prompt symptom alleviation;
• Red Flag Identification: Ruling out clinical markers indicative of a true inflammatory relapse or alternative etiology, such as the emergence of novel focal neurological deficits, progressive stepwise deterioration, symptoms persisting beyond the 24-hour operational threshold, severe atypical pain, or altered sensorium. In febrile presentations, a comprehensive screening for occult infections and concomitant dehydration is mandatory, serving both a differential diagnostic and an immediate therapeutic purpose.

In experimental and scientific research settings, objective quantification of UP and systemic heat sensitivity is frequently achieved via standardized passive heating protocols [55,56]. These methodologies commonly utilize water-perfused thermal suits integrated with multi-domain neurological assessments conducted pre- and post-thermal challenge. In these controlled experimental paradigms, the circulating fluid is typically regulated at approximately 44 °C to 46 °C, aiming to induce a precise, controlled elevation in core body temperature—most frequently by 0.5 °C to 0.6 °C above baseline, verified via objective modalities such as ingestible gastrointestinal thermometry capsules [55].

Conversely, in routine, everyday clinical practice, such provocative thermal testing is rarely warranted and must be approached with extreme caution due to the transient risk of inducing falls or severe central fatigue. Instead, when objective monitoring is clinically indicated, practitioners should rely on validated, heat-neutral functional metrics. These include low-contrast visual acuity charts for visual pathways; the Timed 25-Foot Walk (T25FW), 2-Minute Walk Test (2MWT), or 6-Minute Walk Test (6MWT) for ambulatory endurance; and the Nine-Hole Peg Test (NHPT) for upper extremity fine motor coordination. Cognitive performance can be screened utilizing the Paced Auditory Serial Addition Test (PASAT) or the Symbol Digit Modalities Test (SDMT), which has largely superseded the MMSE in MS-specific care due to its superior sensitivity to processing speed. Postural stability and vestibulocochlear fluctuations can be monitored via the Berg Balance Scale (BBS) or static posturography, while wearable accelerometry offers non-invasive monitoring of gait variability in the patient’s natural environment.

Given that UP is inherently episodic, highly transient, and context-dependent, patient-reported outcomes (PROs) represent an indispensable dimension of its clinical and therapeutic assessment [28]. Structured symptom diaries that meticulously log granular parameters—including ambient meteorological fluctuations, the intensity of physical activity, systemic hydration status, and sleep architecture—are highly valuable for mapping individual thermal thresholds and designing tailored behavioral countermeasures. However, the current psychometric landscape exhibits notable limitations. While several generalized heat sensitivity questionnaires have been deployed across various MS cohorts, a widely adopted, validated clinical instrument specifically designed and psychometrically optimized for UP remains unavailable [28]. This methodological deficit introduces substantial heterogeneity into epidemiological and clinical trials. Consequently, future clinical research must prioritize the development and rigorous validation of responsive, disease-specific PRO instruments. These novel tools must look beyond static symptom severity to dynamically capture multi-domain participation restrictions, particularly those impacting vocational performance, physical rehabilitation compliance, and community mobility. Establishing such standardized metrics is a critical prerequisite for the rigorous, objective evaluation of emerging cooling technologies, physical rehabilitation paradigms, and targeted pharmacological interventions.

6.5. Differential Diagnosis

The paramount objective in the differential evaluation of thermal sensitivity is distinguishing Uhthoff’s phenomenon (UP) from a true, active multiple sclerosis (MS) relapse. This differentiation represents a frequent and complex clinical challenge in routine neuroimmunological practice. As a functional pseudo-relapse, UP reflects a transient conduction failure along chronically demyelinated, vulnerable pathways under thermal duress, operating in the absolute absence of novel focal neuroinflammation [56]. Conversely, a true MS relapse is pathogenetically defined by acute focal inflammatory demyelination and lesion formation within the central nervous system (CNS). Operationally, according to contemporary consensus criteria, a true relapse requires the emergence of novel neurological deficits or the objective, significant escalation of stable symptoms persisting for a minimum 24-hour threshold, occurring in a state of clinical stability and independent of confounding systemic stressors such as pyrexia or occult infection. While not always mandatory for immediate clinical management, true relapses are frequently accompanied by objective changes on standardized neurological examination (e.g., Expanded Disability Status Scale score fluctuations) and may be confirmed via neuroimaging demonstrating novel gadolinium-enhancing or newly active T₂-hyperintense lesions on magnetic resonance imaging (MRI).

Because pyrexia and underlying infectious processes can simultaneously act as immediate physical triggers for UP and coincide temporally with an actual inflammatory relapse, a rigorous, structured diagnostic approach is essential. Clinical priority must be directed toward the prompt screening and eradication of reversible systemic causes—most notably urinary tract and respiratory infections—while systematically monitoring for red flags that denote a true relapse, such as the presentation of anatomically novel, progressive, or persistent neurological deficits that fail to resolve upon the restoration of normothermia.

To ensure a comprehensive differential evaluation, clinical focus must expand beyond MS relapses to encompass a broader spectrum of neuroimmunological, infectious, and metabolic disorders that mimic thermal sensitivity or transient neurological decay. Synthesizing these diagnostic challenges, Panginikkod et al. identified several key conditions that warrant careful consideration during the workup of Uhthoff’s phenomenon-like presentations [8]. These mimics are effectively stratified into distinct etiopathological categories:

• Systemic Autoimmune and Inflammatory Disorders: Central nervous system (CNS) involvement in systemic lupus erythematosus (CNS lupus), neuro-Behçet’s disease, neurosarcoidosis, Sjögren’s syndrome, and primary or secondary CNS vasculitis;
• Infectious Neuro-Pathologies: Neuroborreliosis (Lyme disease), Human Immunodeficiency Virus (HIV) encephalopathy, and Human T-Lymphotropic Virus (HTLV)-associated myelopathy;
• Metabolic, Toxic, and Genetic Leukoencephalopathies: Acquired copper deficiency, osmotic demyelination syndrome (formerly central pontine myelinolysis), and adult-onset leukodystrophies;
• Vascular and Neoplastic Conditions: Cerebral small vessel disease (SVD) and primary or secondary CNS lymphoma.

Systematically screening for these conditions is essential, particularly when a patient presents with atypical red flags—such as a lack of previous MS diagnosis, incomplete symptom resolution upon body cooling, or abnormal neuroimaging findings that do not align with classic demyelinating dissemination in time and space [8].

Table 1. Differential Diagnosis, Pathophysiological Mechanisms, and Clinical Management of Uhthoff’s Phenomenon vs. True Inflammatory Relapse in Multiple Sclerosis.

Feature	Uhthoff’s Phenomenon (Pseudo-Relapse)	True Inflammatory Relapse
Pathophysiological Substrate	Temperature-dependent axonal conduction block; mitochondrial dysfunction and neuroenergetic failure [49]; central autonomic dysregulation [56].	Acute focal autoimmune neuroinflammation; active demyelination; blood-brain barrier disruption with novel lesion formation.
Deficit Pattern	Reversible recrudescence of pre-existing neurological deficits (highly stereotyped and familiar to the patient) [56].	Emergence of novel neurological symptoms or profound, objective escalation of previously stable deficits.
Precipitating Triggers	Exogenous thermal exposure (ambient heat, hot water immersion), metabolic heat (physical exertion) [51,53], systemic pyrexia/infection, or dehydration.	Often idiopathic; may be modulated by chronic systemic stress, the postpartum period, or immunomodulatory therapy non-adherence.
Temporal Kinetics	Rapid onset (minutes); resolves spontaneously upon cooling/rest; typically persists < 24 hours [Note 1].	Prolonged evolution (hours to days); deficits persist > 24–48 hours; recovery occurs gradually over weeks to months.
Objective Examination	Typically unchanged from post-cooling clinical baseline once normothermia is fully restored.	Demonstrates novel, objective focal deficits on standardized neurological examination (e.g., EDSS score shifts).
Neuroimaging (MRI)	No novel demyelinating activity or active lesion load expected.	Frequently demonstrates novel T₂-hyperintense or gadolinium-enhancing lesions (not strictly mandatory for clinical diagnosis).
Immediate Clinical Action	Targeted core body cooling, physical rest, aggressive rehydration; screening/treatment for occult infections; antipyretics.	Verification and exclusion of systemic infection; initiation of high-dose corticosteroid therapy or plasma exchange if indicated.

Table 1. Differential Diagnosis, Pathophysiological Mechanisms, and Clinical Management of Uhthoff’s Phenomenon vs. True Inflammatory Relapse in Multiple Sclerosis.

Feature	Uhthoff’s Phenomenon (Pseudo-Relapse)	True Inflammatory Relapse
Pathophysiological Substrate	Temperature-dependent axonal conduction block; mitochondrial dysfunction and neuroenergetic failure [49]; central autonomic dysregulation [56].	Acute focal autoimmune neuroinflammation; active demyelination; blood-brain barrier disruption with novel lesion formation.
Deficit Pattern	Reversible recrudescence of pre-existing neurological deficits (highly stereotyped and familiar to the patient) [56].	Emergence of novel neurological symptoms or profound, objective escalation of previously stable deficits.
Precipitating Triggers	Exogenous thermal exposure (ambient heat, hot water immersion), metabolic heat (physical exertion) [51,53], systemic pyrexia/infection, or dehydration.	Often idiopathic; may be modulated by chronic systemic stress, the postpartum period, or immunomodulatory therapy non-adherence.
Temporal Kinetics	Rapid onset (minutes); resolves spontaneously upon cooling/rest; typically persists < 24 hours [Note 1].	Prolonged evolution (hours to days); deficits persist > 24–48 hours; recovery occurs gradually over weeks to months.
Objective Examination	Typically unchanged from post-cooling clinical baseline once normothermia is fully restored.	Demonstrates novel, objective focal deficits on standardized neurological examination (e.g., EDSS score shifts).
Neuroimaging (MRI)	No novel demyelinating activity or active lesion load expected.	Frequently demonstrates novel T₂-hyperintense or gadolinium-enhancing lesions (not strictly mandatory for clinical diagnosis).
Immediate Clinical Action	Targeted core body cooling, physical rest, aggressive rehydration; screening/treatment for occult infections; antipyretics.	Verification and exclusion of systemic infection; initiation of high-dose corticosteroid therapy or plasma exchange if indicated.

Notes on Evidence Strength and Methodological Heterogeneity:

• Temporal Thresholds: The 24-hour boundary separating a pseudo-relapse from a true relapse represents an operational consensus definition used in clinical practice, rather than a strictly validated biological threshold established by robust randomized controlled trials (RCTs).
• Symptom Reporting: Because the deficit patterns of Uhthoff’s phenomenon are predominantly self-reported, transient, and context-dependent, clinician assessment must account for inherent recall bias and population heterogeneity (such as regional climate variations and individual metabolic differences) [51].

7. Management and Prevention Strategies

Patient Education and Pragmatic Lifestyle Modifications

The foundational milestone in managing Uhthoff’s phenomenon (UP) relies on structured patient education, with primary clinical emphasis placed on demystifying the transient nature of temperature-dependent functional decay. Patients must be reassured that these acute exacerbations represent fully reversible neuro-functional fluctuations rather than active focal neuroinflammation or definitive disease progression. Clinical experience and small-scale observational cohorts suggest that patients benefit significantly from highly individualized behavioral interventions tailored to prospective meteorological forecasts, travel itineraries, vocational microclimates, and routine activities of daily living [51].

Within this framework of pragmatic guidance, expert consensus frequently recommends scheduling physically demanding tasks and therapeutic exercises during the cooler early morning or late evening hours to minimize metabolic heat accumulation. Additional expert-informed practical strategies encompass maintaining aggressive systemic hydration, utilizing lightweight, highly breathable or moisture-wicking garments, seeking shaded environments, and utilizing air-conditioned spaces whenever feasible [51,55]. Furthermore, patients are advised to restrict or avoid prolonged exposure to high-temperature exogenous sources, such as saunas or hot water immersion. It is critical to acknowledge, however, that while these environmental and lifestyle adaptations are standard in clinical practice, robust evidence from large-scale randomized controlled trials (RCTs) validating their specific clinical efficacy remains sparse; hence, they should be communicated as expert-informed practical guidance rather than strict, evidence-based mandates.